Kenneth C. Frazier
2016
In 2016, Kenneth C. Frazier earned a total compensation of $21.8M as Chairman, President and Chief Executive Officer at Merck & Co., a 10% decrease compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $4,757,350 |
|---|---|
| Non-Equity Incentive Plan | $2,518,425 |
| Option Awards | $4,800,002 |
| Salary | $1,527,404 |
| Stock Awards | $7,875,521 |
| Other | $302,468 |
| Total | $21,781,170 |
Frazier received $7.9M in stock awards, accounting for 36% of the total pay in 2016.
Frazier also received $4.8M of change in pension value and nonqualified deferred compensation earnings, $2.5M in non-equity incentive plan, $4.8M in option awards, $1.5M in salary and $302.5K in other compensation.
Rankings
In 2016, Kenneth C. Frazier's compensation ranked 95th out of 14,075 executives tracked by ExecPay. In other words, Frazier earned more than 99.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 95 out of 14,075 | 99th |
Division Manufacturing | 28 out of 5,488 | 100th |
Major group Chemicals And Allied Products | 8 out of 1,900 | 100th |
Industry group Drugs | 7 out of 1,543 | 100th |
Industry Pharmaceutical Preparations | 7 out of 1,173 | 99th |
Source: SEC filing on April 10, 2017.
Frazier's colleagues
We found four more compensation records of executives who worked with Kenneth C. Frazier at Merck & Co. in 2016.
2016
Adam Schechter
Merck & Co.
Executive Vice President and President, Global Human Health
2016
Robert Davis
Merck & Co.
Chief Financial Officer
2016
Roger Perlmutter
Merck & Co.
Executive Vice President and President, Merck Research Laboratories
2016
Michael Holston
Merck & Co.